In vivo and in vitro studies on the differential role of luteinizing hormone and follicle-stimulating hormone in regulating follicular function in the bonnet monkey (Macaca radiata) using specific gonadotropin antibodies by Selvaraj, N. & Moudgal, N. R.
BIOLOGY OF REPRODUCTION 51, 246-253 (1994)
In Vivo and In Vitro Studies on the Differential Role of Luteinizing Hormone and
Follicle-Stimulating Hormone in Regulating Follicular Function in the Bonnet Monkey
(Macaca radiata) Using Specific Gonadotropin Antibodies'
N. SELVARAJ and N.R. MOUDGAL2
Department of Biochemistry, Primate Research Laboratory, Center for Reproductive Biology and Molecular
Endocrinology, Indian Institute of Science, Bangalore 560 012, India
ABSTRACT
Although a distinct need for FSH in the regulation of follicular maturation in the primate is well recognized, it is not clear
how FSH controls the functionality of different cellular compartments of the follicle. It is also not evident whether there is a
requirement for LH in follicular maturation in the primate. In the first part of the present study, female bonnet monkeys were
administered a well-characterized ovine (o) LH antiserum to neutralize endogenous monkey LH for different periods during the
follicular phase, and the effect on the overall follicular maturation process was assessed by analyzing serum estrogen (E) and
progesterone (P) profiles. Neither continuous LH deprivation from Day 8 of the cycle nor deprivation of LH on any one day
between Days 6 and 10 had a significant effect on serum E and P profiles and the follicular maturation process. The period for
which the antiserum was effective was dependent upon the dose injected; 1 ml of the antiserum given on Day 8 blocked ovulation
but not follicular maturation.
To assess the effect of deprivation of LH/FSH at the cellular level, animals were deprived in vivo of LH (on Days 8 and 9 of
the cycle) or of FSH (on Day 6 of the cycle) by injection of highly characterized hCG and ovine (o) FSH antisera, respectively;
the in vitro responsiveness of granulosa and thecal cells isolated on Day 10 from these animals was then determined. The in
vitro responsiveness of granulosa but not thecal cells to added hCG (2 ng/ml) was inhibited (by 53%) by neutralizing LH in
vivo; granulosa cell responsiveness to added FSH, however, remained unaltered. In contrast, neither granulosa nor thecal cells
isolated on Day 10 of the cycle from animals injected with an FSH antibody on Day 6 responded in vitro to added FSH or LH.
These data suggest that 1) follicular maturation in the nonhuman primate can proceed even when endogenous LH support is
withdrawn from Day 6 onward; 2) while granulosa cells are sensitive to deprivation of LH for the short term, thecal cell func-
tionality appears not to be dependent on LH from Day 6 of cycle onward; and 3) as FSH controls granulosa cell function as well
as thecal cell function (perhaps via paracrine factors), this hormone qualifies as the prime regulator of follicular maturation in
the primate.
INTRODUCTION
The process of follicular maturation in primates can be
broadly classified into recruitment, selection, and domi-
nance, the last phase being accompanied by a burst in func-
tional maturation leading to the formation of an ovulable
follicle [1]. At the cellular level, this involves proliferation
and differentiation of the granulosa and thecal cells and their
ability to respond to both gonadotropins. FSH in turn stim-
ulates the induction of growth factors in addition to aro-
matase responsible for E synthesis in granulosa cells [2, 3].
The adult female bonnet monkey (Macaca radiata), which
has been shown to be an excellent human surrogate model,
exhibits a follicular phase of 11-12 days with an E surge
occurring between Days 8 and 10 and ovulation between
Days 11 and 12 of the cycle [4]. Using characterized FSH
antibody to block FSH action, we have previously shown
that in the female bonnet monkey, FSH is required only
until Day 8 of the cycle, the follicle becoming highly sen-
sitive to the lack of FSH between Days 5 and 7 of the cycle
[4]. Neutralization of FSH on Day 8 or beyond had a very
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negligible effect on the E surge, an index used for deter-
mining completion of follicular maturation. While studies
from other laboratories have essentially confirmed the need
for FSH [5-8], no information is available on exactly how
FSH regulates the function of different cellular compart-
ments in the follicle.
Information on the precise requirement for LH in fol-
licular growth and development is lacking; in particular, since
the need for FSH is restricted to the first 7-8 days of the
cycle [4], we wished to determine whether LH assumes a
dominant role from Day 8 on. Schenken et al. [9] were able
to induce growth of multiple follicles in cynomolgus mon-
keys by administering only "pure FSH" and thus ques-
tioned the relative importance of exogenous LH adminis-
tration during the follicular phase. In light of the success
we have had in the past using specific FSH antibodies to
study the role of FSH in regulation of follicular maturation
in monkeys [4], rodents [10-13], and rabbits [14], in the
present study we used specific LH antibodies to delineate
the role of LH in regulating the overall follicular maturation
process in cycling monkeys. In addition, we have attempted
to understand how FSH and LH regulate the functionality
of different cellular compartments of the follicle by study-
ing how in vivo deprivation of LH or FSH on specific day(s)
of the cycle affected the ability of isolated granulosa and
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thecal cells to respond to these gonadotropins in vitro. This
has enabled us to establish a paracrine role for granulosa
cells in regulating thecal cell functionality.
MATERIALS AND METHODS
Hormones and Chemicals
Human (h) CG (CR127; 14900 IU/mg) and hLH (NIH
AFP 4745B) were kindly provided by Dr. G. Bialy, NICHD,
Bethesda, MD. Ovine (o) FSH (1 ng oFSH corresponds to
1.46 ng hFSH, NIH AFP 4822 B) and LH (1 ng is equivalent
to 0.13 ng hLH AFP 4745B) were purified in our laboratory.
DMEM was from Gibco Labs. (New York, NY); collagenase,
HEPES, and NaHCO3 were from Sigma Chemical Co. (St.
Louis, MO). Tritiated progesterone (P;' 88 Ci/mmol), estra-
diol (E2; 90 Ci/mmol), testosterone (T; 97 Ci/mmol), and
125I Na were purchased from Amersham (UK).
General Methodology
Healthy adult regularly cycling female bonnet monkeys
(M. radiata), 8-12 yr of age, were used. The details of an-
imal husbandry, monitoring of the cycle, and procedure for
collection of blood samples have been previously de-
scribed [15]. All the animal experiments were cleared by
the institutional ethical committee for use of laboratory an-
imals for biomedical research. The day of onset of men-
strual bleeding was considered Day 1 of the cycle. Anti-
serum was administered, when needed, i.v. at 0930 h. Blood
samples were collected at appropriate times from una-
nesthetized monkeys by venipuncture using vacutainer tubes
(Beckton and Dickinson, Rutherford, NJ) as described ear-
lier [4].
Antisera
Antiserum against oFSH was raised in male bonnet mon-
keys as described previously [4]. The oFSH antiserum used
in the current study was from the same pool as used pre-
viously in our laboratory, and the methods for character-
ization of the antiserum for capacity, affinity, cross-reactiv-
ity, and minimum effective dose (MED) were described in
that study [4].
Antibodies capable of blocking endogenous monkey LH
were produced by immunizing donor male bonnet mon-
keys with oLH and adult goats with hCG. The methods used
for immunization are well-standardized laboratory proce-
dures that have been previously described in detail [16].
Methods used for determining the characteristics of the
antisera-such as cross-reactive antibody titer, specificity,
bioneutralization of monkey LH, and MED-were essen-
tially the same for both batches of antisera (oLH and hCG)
and are described in brief below. Since the goat antiserum
to hCG was from a heterologous species, it was precipitated
with 15% Na2SO4 and then extensively dialyzed against water
to obtain the enriched IgG fraction that was used.
To determine the ability of the antisera to bind monkey
LH, the efficacy of the LH/hCG antibody to prevent monkey
pituitary extract (MPE; used as a source of monkey LH) from
inhibiting '25I-hLH binding to sheep luteal membrane was
examined via an LH radioreceptor assay (RRA) described
earlier [17]. An aliquot of MPE (equivalent to 1.9 ng hLH)
was incubated at 4C overnight with different concentra-
tions of oLH/hCG antisera to form an antigen-antibody
complex; then the ability of the complex to inhibit binding
of 125I-hLH to LH receptor was checked in an appropriate
RRA.
Determination of MED of the LH/hCG Antisera
Two types of experiments were conducted to determine
the MED of the LH/hCG antisera. In the first, varying doses
of the LH/hCG antisera (0.05, 0.2, and 1.0 ml for LH; 0.025,
0.05, and 0.1 ml for hCG) were injected on Day 8 of the
cycle to a group of regularly cycling monkeys. Then the
time taken for clearance from circulation of the antibody
cross-reacting with primate LH was assessed by the rate of
disappearance of free antibody capable of binding 125I-hLH.
To 100 Rzl of the serum collected at Time 0 of antiserum
administration and at subsequent time points, 125I-hLH
(-100 000 cpm) was added and the volume was made up
to 0.5 ml with RIA buffer. This was incubated at room tem-
perature for 12-14 h. The bound and free antibody were
separated by addition of polyethylene glycol (PEG 6000;
12.5% final concentration), henceforth called the PEG
method. Five hundred microliters of 25% PEG was added
to the incubation mixture, vortexed, and kept at 40C for 30
min; this was followed by spinning at 1600 x g for 25 min.
The supernatant was discarded; the pellet was suspended
in 1 ml buffer containing 12.5% PEG and subjected to an
additional wash step. The final pellet was monitored for
radioactivity in a multigamma counter. The presence of free
antibody during the various time points after injection of
the antiserum was calculated.
The second model system consisted of determining the
ability of LH/hCG antibody to block the occurrence of the
nocturnal T surge in adult male bonnet monkeys. Before
monkeys were used in the experiment, their serum T levels
at 2200 h of Days -2 and -1 were determined. This was
essentially to establish the normal occurrence of increased
serum T levels at nocturnal times in these monkeys. Dif-
ferent doses of LH/hCG antibody were administered to male
monkeys at 0930 h; serum samples collected at 2200 h of
the same day and the subsequent two days were analyzed
for T level.
Granulosa and Thecal Cell Isolation and Incubation
Protocol
Laparotomy was performed under ketamine anesthesia.
The dominant follicle was aspirated by means of a 24-gauge
needle mounted on a tuberculin syringe. The antrum was
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gently flushed twice to remove the loosely held granulosa
cells with DMEM containing 25 mM HEPES, 0.37% NaHCO 3,
and 0.1% BSA, pH 7.4 [18]. The thecal tissue was excised
and placed in the medium. The follicular aspirate was cen-
trifuged, the fluid was separated, and the cells were sus-
pended in DMEM. The medium obtained from flushing the
follicle was also centrifuged to collect residual granulosa
cells, and the cells thus obtained were all pooled and used.
The thecal tissue was extensively washed to remove any
contaminating granulosa cells and then was subjected to
collagenase digestion essentially according to Stouffer et al.
[19], with slight modifications to obtain single cells. In brief,
this procedure consisted of cutting the thecal tissue into
small pieces, suspending them in DMEM containing 2% BSA
and 0.2% collagenase, and incubating at 37°C in a shaking
water bath for 15 min. Then 2 ml of DMEM containing 2%
BSA was added, and the single cells were released by re-
peatedly aspirating and releasing the suspension with a pi-
pette for about a minute to free the dispersed cells. After
the debris was allowed to settle, the supernatant containing
the cells was aspirated and subjected to a wash step with
the medium. The debris was further digested twice; the su-
pernatants from different digests were pooled, and the cells
collected by centrifugation were washed three times to re-
move excess collagenase before the final cell pellet was
suspended in a fixed volume of medium.
The granulosa and thecal cells in the DMEM medium
were preincubated at 37°C for 30 min in a shaking water
bath followed by washing, and the cells were suspended in
a known volume of medium. Cells were counted in a he-
mocytometer; 5 x 104 viable cells per tube (as determined
by trypan blue exclusion) were incubated in triplicate in
the presence and absence of the gonadotropins (both hCG
and oFSH) in a total volume of 0.5 ml (in 22 x 75-mm glass
tubes) for 3 h at 37°C in a shaking water bath at 60 oscil-
lations per minute. After the incubation, the tubes were kept
frozen at -20°C until assayed for the appropriate steroid
hormone.
Hormone Assays
E2, P, and T assays were carried out as described else-
where [16]. The serum samples were ether extracted twice
and suspended in gelatin PBS (GPBS). The in vitro incu-
bates were assayed for P without any processing. The P and
T antisera used were kind gifts of Dr. Chandana Das, AIIMS,
New Delhi, and Dr. Usha Joshi, IRR, Bombay, respectively.
Characteristics of the P and T antisera used have been de-
scribed by Ravindranath et al. [4] and Moudgal et al. [20],
respectively. The antibody to E2 raised in our laboratory
cross-reacted 3.7% and 1.1% with estrone and estriol, re-
spectively; for P and T, the cross-reactivity was less than
0.1%.
Statistics
Individual experiments were carried out using a mini-
mum of 3-4 animals per group, and the data presented are
means and SEM of replicate experiments. In the in vitro
incubation study, the response to each level of hormone
addition was determined in triplicate. Treatment differ-
ences were analyzed by Student's t-test.
RESULTS
Characteristics of the FSH Antiserum
The FSH antibody used in the current study was from a
pool of monkey antiserum to oFSH whose characteristics
were previously described in detail by Ravindranath et al.
[4]. In brief, the affinity and the capacity of this oFSH anti-
serum to bind hFSH were 0.3 x 10'0 M- ' and 43.3 g/ml,
respectively. This antibody cross-reacted < 10% with hLH
(used as a representative of primate LH). Earlier studies in
adult female cycling monkeys had indicated that the MED
of this antiserum required to neutralize endogenous FSH
action over a 24-h period was 25 l [4].
Characteristics of the Antisera Used to Neutralize LH
The binding affinity and capacity of the monkey anti-
serum to oLH, as determined by Scatchard analysis using
hLH as the radioligand, were 0.12 x 108 M-1 and 33 j.g/
ml hLH, respectively. The corresponding values for the goat
antibody to hCG were 1.3 x 109 M-1 and 405 Rpg/ml hLH,
respectively. The cross-reactivity of both these antibodies
with hFSH was < 8%. In the 125I-hLH receptor assay, the
ability of the monkey pituitary extract (containing 1.9 ng
hLH equivalent) to inhibit labeled ligand binding was blocked
on pre-incubation with either the oLH or the hCG antibody,
and this was a function of antibody concentration. Excess
antibody showed a nonspecific effect due to direct inter-
ference of the antibody with ligand binding; but when the
dose of the antibody became optimal (achieved by adding
decreasing amounts of antibody) there was 100% binding
by the radiolabeled ligand, indicating that monkey LH was
completely bound by the antibody (equivalence zone). In
the case of the hCG and oLH antibodies, this occurred with
28 and 230 ng IgG, respectively.
Determination of MED of the Antibody
Both the LH and hCG antisera were tested in cycling
monkeys for their clearance rate; Figure 1 depicts the re-
sults of a typical experiment with monkey antiserum to oLH
performed in a group of female bonnets on Day 8 of the
cycle. Although after administration of 50 Fl of antiserum
no "free" antibody could be detected by the 125 I-hLH bind-
ing test even at 2 h, injection of 200 ,I1 antiserum revealed
the presence of excess "free" antibody capable of binding
1 25I-hLH in substantial amounts (60% and 37%) at 6 and 24
h, respectively. After administration of 1 ml of antiserum,
appreciable binding (49%) to 125I-hLH could be detected
even 6 days after the injection. These findings indicate that
the duration for which the antibody is effective is a function
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Day of the cycle
FIG. 1. Disappearance of antibody cross-reacting with primate LH as
a function of time after injection of different volumes of monkey antiserum
to oLH on Day 8 of the cycle in female bonnet monkeys. Mean + SEM; n
= 3. Open triangles, 50 1i; open circles, 200 1; open squares, 1 ml
of the dose of antibody injected (Fig. 1) and this is reflected
by the "free" antibody titer. The MED was set at 200 il/
day, as at this dose a substantial amount of free antibody
could still be detected 24 h after injection. The MED of the
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FIG. 2. Effect of administration of different doses of hCG antiserum
(arrow) at 0930 h on serum T level at 2200 h in male bonnet monkeys.
Serum T levels at 2200 h of Days -2, -1, 0, 1, and 2 are provided. Each
of the values is a mean of values for 2 monkeys except during pretreat-
ment, when all 6 monkeys were considered for SEM determination. Solid
circles, pretreatment; open circles, 25 I hCG antibody; open squares, 50
il hCG antibody; open triangles, 100 il hCG antibody
Days from E surge
FIG. 3. Effect of injecting (arrow) 200 i of oLH antiserum on different
days of the cycle on serum E and P profiles during the cycle. Steroid level
(a) in controls and (b-e) after LH antiserum administration on Days -4, -2,
0, and 2 of E surge, respectively. Values represent mean SEM. Number
of monkeys used in each group was 3 or 4 (see Table 1).
hCG antibody as determined in this assay was 25 l (data
not shown).
Figure 2 depicts the results of a typical experiment con-
ducted with different doses of the hCG antiserum (25, 50,
and 100 l) to determine the MED required to block in-
crement in the serum T level at 2200 h (beginning of noc-
turnal T surge). A dose of 25 LI of hCG antibody was ad-
equate to block the elevation in the serum T level seen at
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TABLE 1. Effect of LH deprivation during different periods of follicular phase on cycle length and progesterone
production in the luteal phase.
Total progesterone
secreted during
Day of LH the luteal phase % Change
antiserum Cycle length (Area under the over the
administration* n (days) curve cm2) control
Control 3 28.6 - 0.88 45.04
-4 4 28.0 + 0.81 40.39 -10
-2 4 27.5 - 1.70 32.30 -28
0 3 31.3 ± 1.76 41.45 -8
+2 4 27.0 ± 2.08 37.18 -17
*Day 0 represents day of estrogen surge (normally occurs between Days 8 and 10 of the cycle). Days of LH antibody
administration have been computed with reference to the day of E surge. In all cases the LH antibody was injected
at 0930 h. - = before E surge. + = after E surge.
'Progesterone from Day 2 following E surge to the end of the cycle was considered to compute the area under the
curve.
2200 h, and this effect lasted for only a day (Fig. 2). Admin-
istration of 50 or 100 I1 of hCG antibody resulted not only
in blockade of the nocturnal serum T surge on the day of
treatment but also in substantial inhibition of the nocturnal
serum T increment on the next two days (Fig. 2). The MED
of LH antibody in this assay was 200 pal/monkey/day (data
not provided). The rationale for using the adult male mon-
key model to determine the MED of the two antisera is as
follows. 1) It is known that the LH levels of adult male and
female bonnet monkeys (during the follicular and luteal
phase) are essentially similar [17]; 2) it is easier to procure
adult males in numbers than to procure cycling females
that are all on a particular day of the cycle; and 3) it has
been demonstrated that reduction in serum T levels is a
sensitive indicator of endogenous LH availability [21].
Effect on Cyclic Ovarian Function of Administering LH
Antibody on Different Days of the Follicular Phase
Normally cycling female monkeys (n = 3) receiving 1
ml of oLH antibody on Day 8 of the cycle showed, on lap-
arotomy on Day 14, a single well-developed follicle and no
signs of recent ovulation (lack of follicle with stigmata or
early CL). It is interesting to note that even injection of a
relatively large amount of LH antiserum on the morning of
Day 8 had no effect on the occurrence of the E surge, which
appeared between Days 8 and 10 of the cycle (data not
shown). Administration of 1 ml LH antiserum on Day 8 was
considered (on the basis of data included in Fig. 1) suffi-
cient to block LH at least until Day 14. The block in ovu-
lation (verified at laparotomy) is presumed to have been
due to neutralization of the preovulatory LH surge. The
dominant nonovulated follicle present on Day 14 of the cycle
must, therefore, represent an atretic follicle, as the granu-
losa cells isolated from it in short-term incubation studies
did not respond to added (20 ng/tube) hCG (P secreted:
control, 1.79 + 0.20 vs. experimental, 1.8 0.13 ng/ml/3
h/105 cells). This experiment also provided the first clue
that a block in LH action from Day 8 onward does not lead
to arrest in follicular maturation per se.
Administration of MED of the oLH antibody (200 il/
monkey) on different days of mid-follicular phase had a
negligible effect on the cycle length or the steroid profile
during the cycle. The results are normalized to the day of
the E surge for the purpose of comparison (Fig. 3 and Ta-
ble 1). Deprivation of LH 2 days before or 2 days after the
E surge resulted in a marginal decrease (28% and 17%,
respectively) in production of luteal P. Administration of LH
antibody 4 days before or on the day of the E surge, how-
ever, resulted in virtually no change in occurrence of the
E surge or in luteal P secretion. Cycle length in the treated
animals varied between 27 and 31 days, which was not sig-
nificantly different from the cycle length for controls
(Table 1).
Responsiveness to Added Gonadotropins in Vitro of
Granulosa and Thecal Cells from Animals Deprived of
FSH on Day 6 or LH on Days 8 and 9
For a closer look at the effect that LH and FSH neutral-
ization in vivo produces on the functionality of follicular
cell types, short-term incubations were performed with
granulosa and thecal cells isolated on Day 10 of the cycle
in the presence or absence of added gonadotropins. Our
earlier study [4] showed that the follicular maturation pro-
cess in the bonnet monkey is highly sensitive to FSH de-
privation between Days 5 and 7 of the cycle; consequently
in the current study, we investigated the effect of injection
of FSH antibody on Day 6 of the cycle on granulosa and
thecal cell responsiveness in vitro on Day 10 of the cycle.
Administration of hCG antibody (25 lil) on Days 8 and
9 of the cycle significantly inhibited the responsiveness of
the granulosa cells to added hCG (2 ng/ml). However, these
cells' responsiveness to FSH (20 ng/ml) to secrete P re-
mained unaltered, indicating that deprivation of LH had af-
fected only the homologous responsiveness (Fig. 4). FSH
deprivation on Day 6 of the cycle, however, inhibited the
responsiveness of granulosa cells in vitro to both added
hCG and FSH (Fig. 4). The doses of gonadotropin added
were chosen from a pilot experiment in which the optimal
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FIG. 4. Steroidogenic response to added gonadotropins in vitro of
granulosa cells isolated on Day 10. Cells isolated from: controls, open bars;
animals deprived of LH on Days 8 and 9, crosshatched bars; and animals
deprived of FSH on Day 6, solid bars. Values represent mean SEM of 9
samples. For each hormone level, incubation was carried out in triplicate
(5 x 104) cells per tube) for 3 h at 37'C, and each group comprised 3 an-
imals. For procedural details refer to text. *p < 0.05, **p < 0.005 (Student's
t-test) compared to incubated control.
dose of hCG or FSH needed to maximally stimulate P pro-
duction was determined.
In contrast to findings for the granulosa cells, the re-
sponsiveness of the thecal cells, which possess only LH/CG
receptor, was not affected by LH deprivation on Days 8 and
9 of the cycle (Fig. 5). There was a dose-dependent in-
crease in P production by the thecal cells to added hCG
(0.02, 0.2, and 20 ng/ml); P output in fact was higher than
in the controls. It appeared from this observation that the
thecal cell responsiveness in vitro, which is also a measure
of the presence of a normal quota of LH receptors, is not
influenced by the absence or presence of endogenous LH
support. On the other hand, FSH deprivation on Day 6 led
to a total block in hCG responsiveness of thecal cells on
Day 10; this was particularly interesting since endogenous
LH levels have been shown to remain unaltered after active
immunization against oFSH in monkeys [20].
DISCUSSION
Earlier studies from our laboratory have unequivocally
demonstrated that there is a critical need for FSH in pro-
moting follicular maturation until Day 8 of the cycle, the
follicle becoming extremely sensitive to deprivation of FSH
between Days 5 and 7 of the cycle [4]. Assuming that fol-
licular maturation beyond Day 8 of the cycle and ovulation
(occurring on Day 11 or 12 of cycle) could be regulated
by LH, an attempt was made in the current study to deprive
cycling adult female bonnet monkeys of LH support by ad-
ministering characterized LH antibody on different days
starting from the mid-follicular phase. The batches of LH/
hCG antisera used were specific to-LH and were capable
of bioneutralizing circulatory monkey LH effectively. Their
cross-reactivity with FSH was less than 8%. The affinities of
both the antisera to bind LH were also of a high order. A
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FIG. 5. Steroidogenic response in vitro to added hCG of thecal cells
isolated from Day 10 of the cycle from control and experimental monkeys
receiving different treatments in vivo. Controls, open bars; cells from ani-
mals treated with hCG antibodies on Days 8 and 9, crosshatched bars; cells
from animals treated with FSH antiserum on Day 6, solid bars. P secreted
was quantified by RIA. Values given are mean +- SEM of 9 samples. For
each hormone level, incubation was carried out in triplicate (5 x 104) cells
per tube) and each group consisted of 3 monkeys. *p < 0.05, **p < 0.005
(Student's t-test) compared to incubated control.
variety of in vivo and in vitro methods have been used to
determine the efficacy (to neutralize monkey LH) and MED
of the LH and hCG antisera. On the basis of affinity, capac-
ity, bioneutralizing ability, and clearance of antibody from
circulation, the MED of the LH antibody was set 8 times
higher (200 A1) than that of the hCG antibody (25 !xl).
After administration of 1 ml of LH antiserum on Day 8,
the presence of a mature dominant follicle rather than an
ovulated follicle/CL on Day 14 of the cycle indicated 1) that
continuous neutralization of circulating LH had no effect on
follicular maturation per se and 2) that since ovulation had
not occurred, the quantity of antibody was adequate to block
even the preovulatory LH surge. This treatment also had no
effect on the E surge, indicating that E synthesis beyond
Day 8 is independent of LH support. Confirmation of the
lack of effect on E production was obtained by administer-
ing MED of LH antiserum (200 jzl/monkey) between Days
-4 and 0 (the day of E surge). This finding was in marked
contrast to our earlier observations on FSH antiserum
showing that FSH deprivation up to Day -1, but not be-
yond, results in a drastic reduction in E secretion [4]. The
present study has further shown that blocking LH action for
a 24-h period during the mid-follicular and periovulatory
phase (Day -4 to Day 2 of E surge) has no effect on ovu-
lation, luteal P production, or cycle length. The fact that
MED of LH antibody (200 Rl) did not block ovulation sug-
gests that the dose administered was not adequate to block
the LH surge that precedes ovulation. This set of results, as
far as we are aware, provides the first direct proof that LH
is not needed for the promotion of follicular maturation
per se in the nonhuman primate. In their study on active
immunization of female rhesus monkeys against oLH S-sub-
unit, Thau et al. [22] noted the effect of this treatment on
the occurrence of a short luteal phase but failed to com-
ment on its lack of effect on follicular maturation.
** ** 
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Schenken et al. [9] demonstrated that administration of
a "pure" FSH preparation alone (without exogenous LH)
to normally cycling cynomolgus monkeys could induce
multiple follicles to develop, thus placing into question the
relative importance of LH for follicular maturation. How-
ever, in this model system the role of endogenous LH could
not be discounted. Edelstein et al. [23] observed in women
treated with GnRH agonist that stimulation with human
menopausal gonadotropin or oFSH resulted in similar mean
peak E levels and that the number of oocytes aspirated un-
der both treatments was identical. Schoot et al. [24] were
able to induce follicular growth up to the preovulatory stage
by administering recombinant human FSH to a woman with
congenital gonadotropin deficiency. Despite low E levels
due to a lack of LH, this woman, interestingly, exhibited
normal follicular growth. These in vivo studies are essen-
tially supportive of our contention that FSH and not LH is
the primary regulator of follicular maturation.
The results of the in vitro studies are of particular in-
terest, as these provided insight into the differential sen-
sitivity of the granulosa and thecal cell compartments to
specific LH or FSH deprivation. Although both granulosa
and thecal cells respond to LH, only the former showed
sensitivity to LH deprivation in vivo. The responsiveness of
the granulosa cells to FSH remained unaltered under con-
ditions of LH deprivation in vivo, clearly indicating that the
effect is confined to homologous response only. E synthesis
has been shown to occur in both granulosa and thecal cells
[25], and the aromatase enzyme of at least the granulosa
cell is known to be stimulated by FSH. E synthesis, how-
ever, is dependent upon the availability of androgen pro-
duced in the thecal cells. In vitro studies with thecal cells
isolated from LH-deprived animals, interestingly, showed
that the steroidogenic potential of this cell type is not in-
fluenced (as are granulosa cells) by the lack of LH in vivo.
This perhaps provides a rational explanation for the ob-
servation of no change in serum E levels after LH depri-
vation in vivo. Blocking FSH action for a single day, inter-
estingly, resulted in the granulosa cells losing responsiveness
in vitro to both hCG and FSH. Others have reported a sim-
ilar loss in responsiveness to both added FSH and LH in
vitro in granulosa cells isolated from rabbits pretreated with
FSH antiserum in vivo [14]. It has also been demonstrated
in the marmoset that FSH augments LH-induced steroido-
genesis [26]. These results lend support to the current
thinking that FSH could be regulating steroidogenic re-
sponsiveness of granulosa cells to LH. The current study
has further shown that the in vitro responsiveness of thecal
cells to LH is also influenced by FSH deprivation in vivo.
Considering that administration of FSH antiserum does not
lead to change in LH levels [17] and that thecal cells do not
have FSH receptors, the block in thecal cell responsiveness
to LH in vitro can only be attributed to regulation by FSH
of thecal cell function via granulosa cell-secreted paracrine
factors. The recent demonstration of Smyth et al. [27] that
androgen production of rat thecal cells is modulated by FSH-
stimulated granulosa cell paracrine factors is supportive of
our results.
Various factors such as insulin-like growth factor-1 (IGF-
1), epidermal growth factor, inhibin, activin, tumor necro-
sis factor alpha, etc., have been reported to be synthesized
by primate and rodent granulosa cells [28-33], and at least
some of these factors (e.g., inhibin, IGF-1, etc.) have been
shown to be increased by FSH in a dose-dependent manner
[34]. These factors in turn modulate gonadotropin-stimu-
lated E production by the granulosa cells [31]. Hillier et al.
[35] have demonstrated that inhibin and IGF-1 have a para-
crine role in modulating LH-stimulated thecal androgen
biosynthesis in the human ovary. From the foregoing it is
apparent that of the two gonadotropins, the need for FSH
in regulating follicular maturation is paramount, as FSH
controls-in addition to granulosa cell proliferation-the
functionality of both granulosa and thecal cells of the ma-
turing follicle via autocrine/paracrine factors put out by the
granulosa cells. The nature of these factors needs to be es-
tablished.
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